Immunosuppressants are a class of compounds that reduce the effects of an activated immunesystem. These compounds have been clinically effective at suppressing organ graft rejection and in the treatment of autoimmune diseases. The most widely used immunosuppressants are natural products originally isolated from microorganism cultures. Amongthese products, cyclosporin A, FK-506, and rapamycin are probably the most well known.^In our previous study, we isolated dykellic acid from the fermentation broth of Westerdykella multispora F50733 by silica gel and Sephadex LH-20 chromatography and reported that this compound inhibits etoposide-induced apoptosis in U937 cells. Its structure was determined by NMRspectroscopy and X-ray crystallography ( Fig. 1). 2)
Here we demonstrate that dykellic acid has immunosuppressive activity.
Materials and Methods

Analysis of B Cell Functions
Lipopolysaccharide (LPS) was used to induce mitogenic stimulation and antibody secretion in B cells, as described previously.
3) The proliferation of B cells was induced with 5^g/ml of LPS, and dykellic acid was then added at concentrations of 3 to 30 /ig/ml on Day 0. 
Analysis of T Cell Functions
Antigen-nonspecific and alloantigen-speciflc proliferation of T cells was induced with 5/ig/ml of concanavalin A proliferation ( Fig. 2A ) and the polyclonal IgM antibody production ( Fig. 2B ) ofB cells in a dose dependent manner.
Dykellic acid also inhibited the proliferation of T cells in response to Con A (Fig. 3A) and alloantigen in MLR (Fig.  3B) . Furthermore, dykellic acid also inhibited the IL-2 and IL-4 gene expression of Th cells (Fig. 3C) . Finally, we verified that dykellic acid did not induce cell death by quantifying cell death by propidium iodide dye uptake assay. As shown in Fig. 4 , dykellic acid did not induce cell death at the fully active concentration of 30^g/ml. In addition, this compound did not affect the growth of 14 kinds of cancer cells such as HT-29, HT1080, A549, UO-31, B16F10, SNB75, UACC 62, SW620, NCI-H23, MM-231, PC-3, ACHN, P388, and EL4, showing more than 100/ig/ml of 50% growth inhibition value (data not shown).
In the present study, the immunosuppressive activity of dykellic acid is described for the first time. blocks Gl-to-S phase progression of the cell cycles. In the present study, we demonstrate that the cell-type selectivity of dykellic acid is similar to that of rapamycin, and differs 
